President Yoon Suk-yeol on Tuesday hailed the successful launch and complimented everyone involved in the Nuri rocket project, saying that South Korea’s space challenges were “just beginning.” He also underlined a pledge from his presidential election campaign to establish a state-level aerospace agency, which would supervise all of the country’s aerospace projects. Leading up to the presidenti...

South Korea’s homegrown rocket Nuri is ready for blastoff on Tuesday, with hopes to deliver a complete and successful launch this time to officially signal the country’s entrance into the global space race. The Korea Aerospace Research Institute said Monday that Nuri, also known as the Korea Space Launch Vehicle-II, has been erected on the launch pad at Naro Space Center in the southern coastal ...

SAN DIEGO -- Over 250 Korean companies participated in this year’s BIO International Convention, the world’s largest biotechnology industry gathering that took place in person for the first time in three years. Except in the cases of big companies such as Celltrion and Samsung Biologics, most of the small biotech companies were scrapping to present their pipelines and technologies to the global ...

KT and Hanmi Pharmaceutical have jointly invested in digital therapeutics developer Digital Pharm, officials said Sunday. With the investment, KT will be in charge of developing platforms for digital therapeutics, drafting business strategies and providing pipelines. Meanwhile, Hanmi plans to maximize synergetic impact through hospital-specialized marketing and supporting the authorization of di...

SAN DIEGO -- Samsung Biologics, the world’s largest contract development and manufacturing organization by production capacity, will join the global RE100 renewable energy initiative as early as next month, a source familiar with the matter said Wednesday. Led by the Climate Group in partnership with CDP, formerly known as Carbon Disclosure Project, the RE100 initiative commits members to using ...

SAN DIEGO -- Samsung Biologics CEO John Rim said Monday the US states of California, North Carolina, Washington and Texas are the strongest candidates the South Korean contract manufacturing organization is considering for its first overseas production facility. Pointing out that some of the US’ major bio clusters are located in those four states, the CEO added that the CMO giant has not made an...

SAN DIEGO -- South Korea became one of the countries with the largest number of companies taking part in this year’s BIO International Convention, showing how Asia’s fourth-largest economy has become a rising player in the global biotechnology industry. According to a biotech industry official participating in the convention in San Diego, over 3,200 companies from across the globe signed up to a...

SAN DIEGO -- Samsung Biologics is showcasing its top-tier production capacities at the world’s largest biopharmaceutical exhibition, the South Korean company said Monday. Taking part in the BIO International Convention for the 10th consecutive year, Samsung Biologics has set up a sizable 140-square-meter booth to represent its world-leading production capacity as one of the largest contract and ...

“The current Meta CPR 1.0 is for conducting CPR on adults. But other countries have shown interests in teaching young couples how to properly conduct CPR for children. South Korea’s police and firefighter authorities have asked for ways to educate more trainees with our solution as the current head-mounted display only allows for one-on-one training,” he said. The official added that the company...

Lotte Biologics has picked Lee Won-jik, a former Samsung Biologics executive, to lead its bio business as the company’s CEO. Born in 1977, Lee has over two decades of experience in global biologics and the pharmaceuticals industry, including working at the US Department of Health and Human Services and Bristol Myers Squibb. Before he joined Lotte in August, Lee was the head of Samsung Biologics’...

Kakao Pay shares tumbled Wednesday morning after it was reported that its second-largest shareholder Alipay was looking to sell 5 million shares -- about 10 percent of the total stake it holds in Kakao Pay -- in a block deal. The stock price of Kakao Pay fell 15.57 percent to close at 89,500 won. Despite the sell-off, the payment arm of IT giant Kakao said Alipay will continue to be a strategic ...

Samsung Biologics has signed an intent letter for a contract manufacturing organization deal worth $81 million with multinational pharmaceutical firm Norvatis Pharma, the South Korean company announced Tuesday. According to the contract manufacturing giant’s regulatory filing, the two sides on Friday signed the initial contract, which is equivalent to 6.41 percent of the company’s annual sales o...